All

Non-invasive Prenatal Testing Service Launched

Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.

All

Prenatal Diagnosis Linked to Earlier Congenital Heart Disease Surgery

A new study shows that prenatal diagnosis is associated with earlier surgery for babies with congenital heart defects.

All

FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests

The FDA is warning the public of the risk of false results, inappropriate use, and inappropriate interpretation of results with NIPS tests.

PreciseMDX Automates and Simplifies Diagnostic Testing

Aug 30, 2021 | Disease States

PreciseMDX introduces a cloud-based solution that automates and simplifies the diagnostic testing experience.

BioReference Laboratories Acquires Prenatal Testing Business from Roche

Aug 16, 2021 | Company News, Prenatal Testing

BioReference Laboratories, Inc. has acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche.

EchelonDx, Cradle Genomics Join Forces on Non-Invasive Prenatal Diagnostic Products

May 5, 2021 | Prenatal Testing

As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.

Scientists Develop Blood Test to Predict Environmental Harms to Children

Feb 25, 2021 | Prenatal Testing

The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.

Sera Prognostics PreTRM Blood Test Gets CPT PLA Code

Feb 5, 2021 | Prenatal Testing

The new CPT PLA code will facilitate billing and payment for the PreTRM Test, the company’s proprietary proteomic blood test for measuring a woman’s risk of spontaneous preterm birth to enable timely intervention.

Sera Prognostics, Anthem Launch Study to Improve Outcomes for Preterm Babies

Jan 5, 2021 | Prenatal Testing, Research

The PRIME study is designed to provide a blueprint for how healthcare can more effectively identify and manage high-risk pregnancies and reduce preterm birth.

Protein Linked to Gestational Diabetes

Dec 7, 2020 | Diabetes & Metabolic Diseases, Prenatal Testing, Research

A new study outlines a role for pregnancy-associated plasma protein A in gestational diabetes, with potential as a diagnostic tool and therapeutic target.

Progenity Test for Triaging Preeclampsia Passes Key Development Milestone

Nov 20, 2020 | Prenatal Testing

This proprietary test is a multi-analyte protein biomarker assay which is designed to be run from a simple blood draw.

Study: Enhanced Common Blood Test Could Predict Adverse Outcomes in Pregnancy

Oct 29, 2020 | Diabetes & Metabolic Diseases, Prenatal Testing

A blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.

Myriad’s Amplify Technology Improves Prequel NIPS Test

Aug 4, 2020 | Molecular Diagnostics, Prenatal Testing

The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.

First Customizable Noninvasive Prenatal Test for Single-Gene Disorders

May 13, 2019 | Prenatal Testing, Standards

The test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.